Primary Site >> Colorectal Cancer
Gene >> RBM3
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|
|
Ref: Translation regulatory factor RBM3 is a proto-oncogene that prevents mitotic catastrophe. PMID: 18427544 |
Ref: Nuclear expression of the RNA-binding protein RBM3 is associated with an improved clinical outcome in breast cancer. PMID: 19734850 |
Ref: The RNA-binding protein RBM3 is required for cell proliferation and protects against serum deprivation-induced cell death. PMID: 19770690 |
Ref: High RBM3 expression in prostate cancer independently predicts a reduced risk of biochemical recurrence and disease progression. PMID: 21955582 Ref: High nuclear RBM3 expression is associated with an improved prognosis in colorectal cancer. PMID: 21956899 |
Ref: The prognostic factors and multiple biomarkers in young patients with colorectal cancer. PMID: 26013439 |
Ref: Loss of RNA-binding motif protein 3 expression is associated with right-sided localization and poor prognosis in colorectal cancer. PMID: 25922889 Ref: RNA binding protein RBM3 increases beta-catenin signaling to increase stem cell characteristics in colorectal cancer cells. PMID: 26331352 |
Ref: Expression of RNA-binding Motif Protein 3 (RBM3) and Cold-inducible RNA-binding protein (CIRP) Is Associated with Improved Clinical Outcome in Patients with Colon Cancer. PMID: 28373441 Ref: High RNA-Binding Motif Protein 3 (RBM3) Expression is Independently Associated with Prolonged Overall Survival in Intestinal-Type Gastric Cancer. PMID: 29263314 |
Ref: High RNA-binding Motif Protein 3 Expression Is Associated with Improved Clinical Outcomes in Invasive Breast Cancer. PMID: 30275857 |